Cybersecurity for Life Sciences organizations: Research and development with peace of mind
The key to innovation in life sciences is set around data. Collecting, analyzing and sharing valuable information between researchers paves the way to excellence. To gain efficiency, pharmaceutical organizations are adopting innovative technologies, such as Cloud or connected medical devices, that will help them optimize their supply chain.
Enhancing life sciences cybersecurity with a specialized partner
In today’s more and more interconnected world, life sciences companies need to adopt the right processes and technologies to get closer to the market and become more competitive.
Atos has led several projects in the pharmaceutical field, each requiring IT and operational technology (OT) knowledge to protect intellectual property.
Proven use cases
Expert teams in life sciences support security projects. Connected medical device assessment, supply chain protection, security audit and traceability.
Extensive knowledge base shared through 15 SOCs worldwide with 6000+ highly experienced and certified security professionals.
From assessment to deployment, services and products for tailored cybersecurity operations that adhere to your local regulations.
Own developed and complementary products for a tailored experience and a comprehensive security platform.
End-to-end cybersecurity for life sciences solutions
Atos delivers robust, comprehensive cybersecurity solutions that protect life sciences organizations on any device and across different environments (IT/OT/IoT), saving operational downtime.
What our customers say about us
Costly downtime in the supply chain, such as when a user types the wrong password in applications, impacts production. This worldwide pharmaceutical company wanted to implement biometric authentication for drugs manufacturing enterprise system (MES) in shop floors to ease the process and increase security.
They selected Evidian Enterprise SSO and Authentication manager, with a wearable biometric solution for handsfree strong authentication.
The company reduced its IT costs and, with improved productivity, additional drugs were produced, resulting in improved return on investment.
Cybersecurity Business Development Manager, Healthcare & Life Sciences